Altimmune, Inc.
ALT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $37 | $135 | $111 | $190 |
| Short-Term Investments | $95 | $63 | $74 | $0 |
| Receivables | $3 | $5 | $3 | $6 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $7 | $5 | $8 |
| Total Curr. Assets | $137 | $210 | $193 | $204 |
| Property Plant & Equip (Net) | $0 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $12 | $12 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $0 | $1 | $1 |
| Total NC Assets | $2 | $1 | $14 | $15 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $139 | $211 | $207 | $219 |
| Liabilities | – | – | – | – |
| Payables | $0 | $2 | $5 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $1 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $10 | $10 | $11 | $16 |
| Total Curr. Liab. | $10 | $12 | $17 | $18 |
| LT Debt | $1 | $0 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $4 | $4 | $0 |
| Total NC Liab. | $5 | $4 | $5 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $1 | $1 | $2 |
| Total Liabilities | $16 | $17 | $22 | $20 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$561 | -$466 | -$378 | -$293 |
| AOCI | -$5 | -$5 | -$5 | -$5 |
| Other Equity | $690 | $665 | $568 | $497 |
| Total Equity | $124 | $194 | $185 | $199 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $139 | $211 | $207 | $219 |
| Net Debt | -$35 | -$134 | -$110 | -$189 |